JP Patent

JP2023517312A — ヒト免疫不全ウイルスの複製阻害剤

Assigned to ViiV Healthcare UK No 5 Ltd · Expires 2023-04-25 · 3y expired

What this patent protects

式Ｉの化合物（その薬学的に許容可能な塩を含む）：【化１】TIFF2023517312000044.tif122170並びにヒト免疫不全ウイルス（ＨＩＶ）感染症を処置するための組成物及び方法が記載される。

USPTO Abstract

式Ｉの化合物（その薬学的に許容可能な塩を含む）：【化１】TIFF2023517312000044.tif122170並びにヒト免疫不全ウイルス（ＨＩＶ）感染症を処置するための組成物及び方法が記載される。

Drugs covered by this patent

Patent Metadata

Patent number
JP2023517312A
Jurisdiction
JP
Classification
—
Expires
2023-04-25
Drug substance claim
No
Drug product claim
No
Assignee
ViiV Healthcare UK No 5 Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.